kdakota630 (32.86)

Sectors With The Most Picks

Metals and Mining

 
123 Outperform
 
16 Underperform

Oil, Gas and Consumable Fuels

 
81 Outperform
 
47 Underperform

Dedicated Short Bias Funds

 
23 Outperform
 
93 Underperform

Commercial Banks

 
3 Outperform
 
63 Underperform

Thrifts and Mortgage Finance

 
0 Outperform
 
63 Underperform

Media

 
3 Outperform
 
52 Underperform

Household Durables

 
5 Outperform
 
35 Underperform

Specialty Retail

 
7 Outperform
 
33 Underperform

Specialty/Miscellaneous Funds

 
9 Outperform
 
31 Underperform

Software

 
13 Outperform
 
26 Underperform

Electrical Equipment

 
3 Outperform
 
34 Underperform

Real Estate Investment Trusts (REITs)

 
0 Outperform
 
34 Underperform

Pharmaceuticals

Outperform
Ticker Company Name Pick Date Score
View all Tickers in Tag
PMC PharMerica Corporation 8/24/2010 +37.37
DSCO Discovery Laboratories Inc 2/16/2011 +13.87
BSPM Biostar Pharmaceuticals, Inc. 9/20/2010 +7.73
MRK Merck & Co., Inc. 11/29/2007 +1.45
JNJ Johnson & Johnson 11/26/2007 +0.45
BMY Bristol-Myers Squibb Co. 12/5/2007 -19.09
Underperform
Ticker Company Name Pick Date Score
View all Tickers in Tag
WPHM Winston Pharmaceuticals, Inc. 5/1/2009 +83.51
EMIS Emisphere Technologies, Inc. 10/24/2011 +77.49
SGYP Synergy Pharmaceuticals Inc Fl 2/12/2010 +47.10
WPHM Winston Pharmaceuticals, Inc. 1/30/2009 +41.45
FCPG First China Pharmaceutical Group, Inc. 4/26/2011 +39.13
OHRP Ohr Opco, Inc. 12/23/2015 +34.52
NVGN Novogen Limited (ADR) 2/20/2013 +33.73
OHRP Ohr Opco, Inc. 7/16/2015 +25.53
RPRX Repros Theraup 2/12/2009 +24.44
COCP Cocrystal Pharma, Inc. 12/31/2015 +22.16
OHRP Ohr Opco, Inc. 7/30/2015 +21.55
PVCT Provectus Pharmaceuticals, Inc. 12/30/2014 +21.44
NVGN Novogen Limited (ADR) 2/28/2013 +19.94
RPRX Repros Theraup 1/12/2009 +19.93
FCPG First China Pharmaceutical Group, Inc. 3/2/2011 +14.86
FCPG First China Pharmaceutical Group, Inc. 3/24/2011 +14.03
EMIS Emisphere Technologies, Inc. 10/26/2010 +13.60
FCPG First China Pharmaceutical Group, Inc. 12/20/2010 +13.47
FCPG First China Pharmaceutical Group, Inc. 3/11/2011 +13.05
FCPG First China Pharmaceutical Group, Inc. 5/5/2011 +12.68
FCPG First China Pharmaceutical Group, Inc. 12/29/2010 +12.61
COCP Cocrystal Pharma, Inc. 2/27/2015 +10.06
RPRX Repros Theraup 3/25/2011 +8.63
RPRX Repros Theraup 3/17/2011 +8.27
RPRX Repros Theraup 3/4/2011 +8.13
PFE Pfizer, Inc. 11/28/2007 +0.01

Machinery

 
25 Outperform
 
6 Underperform

Consumer Finance

 
2 Outperform
 
28 Underperform

Chemicals

 
25 Outperform
 
5 Underperform

Capital Markets

 
4 Outperform
 
25 Underperform

Hotels, Restaurants and Leisure

 
5 Outperform
 
22 Underperform

Insurance

 
2 Outperform
 
24 Underperform

Internet Software and Services

 
3 Outperform
 
22 Underperform

Communications Equipment

 
8 Outperform
 
14 Underperform

Natural Resources Funds

 
9 Outperform
 
10 Underperform

Commercial Services and Supplies

 
5 Outperform
 
9 Underperform

Emerging Markets Funds

 
4 Outperform
 
9 Underperform

Electronic Equipment, Instruments and Components

 
4 Outperform
 
9 Underperform

General U.S. Treasury Funds

 
0 Outperform
 
12 Underperform

Healthcare Equipment and Supplies

 
4 Outperform
 
7 Underperform

Construction and Engineering

 
9 Outperform
 
0 Underperform

International Multi-Cap Core

 
0 Outperform
 
8 Underperform

Automobiles

 
2 Outperform
 
6 Underperform

Multiline Retail

 
0 Outperform
 
7 Underperform

Computers and Peripherals

 
6 Outperform
 
1 Underperform

Auto Components

 
3 Outperform
 
4 Underperform

Internet and Catalog Retail

 
1 Outperform
 
5 Underperform

Financial Services Funds

 
2 Outperform
 
4 Underperform

Gold Oriented Funds

 
5 Outperform
 
0 Underperform

Professional Services

 
1 Outperform
 
2 Underperform

Water Utilities

 
0 Outperform
 
3 Underperform

Science & Technology Funds

 
0 Outperform
 
2 Underperform

Food and Staples Retailing

 
1 Outperform
 
0 Underperform

Real Estate Funds

 
0 Outperform
 
1 Underperform

Diversified Leverage Funds

 
1 Outperform
 
0 Underperform

Consumer Goods Funds

 
0 Outperform
 
0 Underperform

Featured Broker Partners